Small-Molecule Inhibitors of Protein-Protein Interactions by Lyubomir VassilevSmall-Molecule Inhibitors of Protein-Protein Interactions by Lyubomir Vassilev

Small-Molecule Inhibitors of Protein-Protein Interactions

EditorLyubomir Vassilev, David Fry

Paperback | February 27, 2013

Pricing and Purchase Info

$306.34 online 
$336.95 list price save 9%
Earn 1532 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

In this volume, the editors have collected the knowledgeable insights of a number of leaders in this field - researchers who have achieved success in addressing the difficult problem of inhibiting protein-protein interactions. These researchers describe their unique approaches, and share experiences, results, thoughts, and opinions. The content of the articles is rich, and in terms of scope ranges from generalized approaches to specific case studies. There are various focal points, including methodologies and the molecules themselves. Ultimately, there are numerous lessons to be taken away from this collection, and the editors hope that this snapshot of the current state of the art in developing protein-protein inhibitors not only pays tribute to the past successes, but also generates excitement about the future potential of this field
Title:Small-Molecule Inhibitors of Protein-Protein InteractionsFormat:PaperbackDimensions:184 pages, 9.25 × 6.1 × 0 inPublished:February 27, 2013Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642266703

ISBN - 13:9783642266706

Look for similar items by category:

Customer Reviews of Small-Molecule Inhibitors of Protein-Protein Interactions

Reviews

Table of Contents

Preface.- Hydrogen-bonded synthetic mimics of protein secondary structure as disruptors of protein-protein interactions.- Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied.- Small molecule inhibitors of the human papillomavirus E1-E2 interaction.- Design of small-molecule Smac mimetics as IAP antagonists.- Small-molecule inhibitors reveal a new function for Bcl-2 as a pro-angiogenic signaling molecule.- Small-molecule modulators of c-Myc/Max and Max/Max interactions.-  Small-molecule inhibitors of the p53-MDM2 interaction.- Subject index